cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications (Q38220091)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

cGMP: transition from bench to bedside: a report of the 6th International Conference on cGMP Generators, Effectors and Therapeutic Implications (English)

1 reference

Europe PubMed Central

31 August 2017

author name string

Linda S Hoffmann

1

1 reference

Europe PubMed Central

31 August 2017

Horng H Chen

2

1 reference

Europe PubMed Central

31 August 2017

publication date

15 June 2014

1 reference

Europe PubMed Central

31 August 2017

Naunyn-Schmiedeberg's Archives of Pharmacology

1 reference

Europe PubMed Central

31 August 2017

387

1 reference

Europe PubMed Central

31 August 2017

8

1 reference

Europe PubMed Central

31 August 2017

707-718

1 reference

Europe PubMed Central

31 August 2017

https://scigraph.springernature.com/pub.10.1007/s00210-014-0999-8

0 references

Crystal structures of the catalytic domain of human soluble guanylate cyclase

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Atrial natriuretic peptide is negatively regulated by microRNA-425.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Subcutaneous administration of brain natriuretic peptide in experimental heart failure.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Structure and regulation of soluble guanylate cyclase

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Dysfunctional nitric oxide signalling increases risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Riociguat for the treatment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzyme

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Nitric oxide regulation of cyclic di-GMP synthesis and hydrolysis in Shewanella woodyi

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Soluble guanylate cyclase modulators in heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

The changed metabolic world with human brown adipose tissue: therapeutic visions.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Regulation of metabolism by cGMP.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Nitroglycerin fails to lower blood pressure in redox-dead Cys42Ser PKG1α knock-in mouse

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Protein kinase G oxidation is a major cause of injury during sepsis.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Bifurcation of axons from cranial sensory neurons is disabled in the absence of Npr2-induced cGMP signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Transgenic mice for cGMP imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Higher-order interactions bridge the nitric oxide receptor and catalytic domains of soluble guanylate cyclase.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

A uroguanylin-GUCY2C endocrine axis regulates feeding in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00210-014-0999-8

21 January 2018

CD-NP, a chimeric natriuretic peptide for the treatment of heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution and development of brown adipocytes in the murine and human adipose organ

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of cellular expression with function of NO-sensitive guanylyl cyclase in the murine lower urinary tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cGMP promotes healthy expansion and browning of white adipose tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24927824

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00210-014-0999-8

1 reference

Europe PubMed Central

31 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

31 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38220091&oldid=1747961015"